Cargando…
Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
Significant advances have been made to identify effective therapies that either restore or generate de novo a patient’s immune response to cancer, so-called immunotherapy or immuno-oncology (IO) therapies. Some tumors overcome immune surveillance by promoting mechanisms to evade or suppress the immu...
Autores principales: | Wilkinson, Robert W., Leishman, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992967/ https://www.ncbi.nlm.nih.gov/pubmed/29910800 http://dx.doi.org/10.3389/fimmu.2018.01082 |
Ejemplares similares
-
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
por: Lee, Yun Hua, et al.
Publicado: (2020) -
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
por: Waibl Polania, Jessica, et al.
Publicado: (2021) -
A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy
por: Guram, Kripa, et al.
Publicado: (2019) -
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
por: Roy, Dia, et al.
Publicado: (2023) -
Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology
por: Liu, Zefan, et al.
Publicado: (2022)